Current Allergy and Asthma Reports

, Volume 12, Issue 3, pp 246–254

Treatment Update in Multiple Sclerosis

ALLERGIC AND IMMUNOLOGIC DISORDERS OF THE EYE AND NERVOUS SYSTEM (CH KATELARIS, SECTION EDITOR)

DOI: 10.1007/s11882-012-0256-5

Cite this article as:
Morris, K. & Yiannikas, C. Curr Allergy Asthma Rep (2012) 12: 246. doi:10.1007/s11882-012-0256-5

Abstract

Multiple sclerosis is the most common cause of disability in young people in the Western world. Reduced life expectancy and worsening quality of life due to increasing disability later in the disease course have significant personal and societal costs. Changes in treatment strategies and newly available treatments hope to improve the outlook for our often young patients. This paper details currently available treatments and some that are expected to reach the market shortly.

Keywords

Multiple sclerosisTreatmentAlgorithmInterferon-betaGlatiramer acetateNatalizumabMitoxantroneFingolimodDimethyl fumarateCladribineAlemtuzumabRituximab

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Concord Repatriation General HospitalBurwoodAustralia